Search research articles
Contact Us
Filters
Showing results (491-500 of 512) with videos related to
Page
of 52
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2025
Ribociclib-letrozole combination as an alternative for neoadjuvant chemotherapy in selected post-menopausal patients with luminal breast cancer (BOOG 2017-01)
Anne F de Groot, Danielle Cohen, Joan B Heijns, et al.
Nuclear Medicine Communications
|
May 3, 2023
Baseline and early digital [ 18 F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study
Floris A Vuijk, Shirin Feshtali Shahbazi, Wyanne A Noortman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 23, 2020
Erratum to "Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial" [Radiother. Oncol. 147 (2020) 75-83]
Maxime J M van der Valk, Corrie A M Marijnen, Boudewijn van Etten, et al.
Plos One
|
February 9, 2018
Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures
Judith Kooiman, Jean-Paul P M de Vries, Jan Van der Heyden, et al.
Breast Cancer Research : BCR
|
August 29, 2019
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)
Stefanie de Groot, Hanno Pijl, Ayoub Charehbili, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2020
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial
Maxime J M van der Valk, Corrie A M Marijnen, Boudewijn van Etten, et al.
The New England Journal of Medicine
|
October 2, 2014
Randomized feeding intervention in infants at high risk for celiac disease
Sabine L Vriezinga, Renata Auricchio, Enzo Bravi, et al.
Obstetrical & Gynecological Survey
|
December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
The Lancet. Oncology
|
September 8, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
Nature Communications
|
June 25, 2020
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial
Stefanie de Groot, Rieneke T Lugtenberg, Danielle Cohen, et al.
Page
of 52
Search research articles
Search
Showing results (491-500 of 512) with videos related to
Sort By:
Page
of 52
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2025
Ribociclib-letrozole combination as an alternative for neoadjuvant chemotherapy in selected post-menopausal patients with luminal breast cancer (BOOG 2017-01)
Anne F de Groot, Danielle Cohen, Joan B Heijns, et al.
Nuclear Medicine Communications
|
May 3, 2023
Baseline and early digital [ 18 F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study
Floris A Vuijk, Shirin Feshtali Shahbazi, Wyanne A Noortman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 23, 2020
Erratum to "Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial" [Radiother. Oncol. 147 (2020) 75-83]
Maxime J M van der Valk, Corrie A M Marijnen, Boudewijn van Etten, et al.
Plos One
|
February 9, 2018
Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures
Judith Kooiman, Jean-Paul P M de Vries, Jan Van der Heyden, et al.
Breast Cancer Research : BCR
|
August 29, 2019
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)
Stefanie de Groot, Hanno Pijl, Ayoub Charehbili, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2020
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial
Maxime J M van der Valk, Corrie A M Marijnen, Boudewijn van Etten, et al.
The New England Journal of Medicine
|
October 2, 2014
Randomized feeding intervention in infants at high risk for celiac disease
Sabine L Vriezinga, Renata Auricchio, Enzo Bravi, et al.
Obstetrical & Gynecological Survey
|
December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
The Lancet. Oncology
|
September 8, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
Nature Communications
|
June 25, 2020
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial
Stefanie de Groot, Rieneke T Lugtenberg, Danielle Cohen, et al.
Page
of 52